Semi-Annual Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7714056

Concept 2018-04-01 to
2018-12-31
2017-04-01 to
2017-12-31
Semi-annual statement of income
Statement of income
Net sales
154,621,000 JPY
246,634,000 JPY
Cost of sales
70,147,000 JPY
240,058,000 JPY
Ordinary profit (loss)
-1,272,609,000 JPY
-1,172,418,000 JPY
Gross profit (loss)
84,473,000 JPY
6,576,000 JPY
Selling, general and administrative expenses
1,364,532,000 JPY
1,176,105,000 JPY
Extraordinary losses
194,215,000 JPY
JPY
Selling, general and administrative expenses
Operating profit (loss)
-1,280,059,000 JPY
-1,169,529,000 JPY
Profit (loss) before income taxes
-1,466,825,000 JPY
-1,172,418,000 JPY
Income taxes - current
2,887,000 JPY
3,572,000 JPY
Non-operating income
11,349,000 JPY
341,000 JPY
Income taxes - deferred
234,000 JPY
696,000 JPY
Non-operating income
Interest income
31,000 JPY
23,000 JPY
Income taxes
3,122,000 JPY
4,268,000 JPY
Non-operating expenses
3,899,000 JPY
3,230,000 JPY
Profit (loss)
-1,469,947,000 JPY
-1,176,687,000 JPY
Non-operating expenses
Extraordinary losses
Impairment losses
193,800,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.